Glufast On Insulin Glargine Trial in Type 2 DM

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2008
We will evaluate the efficacy and safety of combination therapy of 10 mg mitiglinide or 0.2mg voglibose with insulin glargine for 16 weeks after single administration of insulin glargine for 4 weeks in type 2 diabetic patients whose glycemic control were not enough despite administration of oral antidiabetic drug or insulin glargine.
Epistemonikos ID: d3d751387ef96d3fe340e94d537bcd2bb9fc671d
First added on: May 05, 2024